Reports

- Global Locations -

Headquarters

Future Market Insights, Inc.

Christiana Corporate, 200
Continental Drive, Suite 401,
Newark, Delaware - 19713,
United States

T: +1-845-579-5705

Americas

Future Market Insights, Inc.

616 Corporate Way, Suite 2-9018,
Valley Cottage, NY 10989, United States

T: +1-347-918-3531

MEA

Future Market Insights

1602-6 Jumeirah Bay X2 Tower, Plot No: JLT-PH2-X2A,
Jumeirah Lakes Towers, Dubai,
United Arab Emirates

Europe

Future Market Insights

3rd Floor, 207 Regent Street,
W1B 3HH London
United Kingdom

T: + 44 (0) 20 8123 9659
D: +44 (0) 20 3287 4268

Asia Pacific

Future Market Insights

IndiaLand Global Tech Park, Unit UG-1, Behind Grand HighStreet, Phase 1, Hinjawadi, MH, Pune – 411057, India

Analytical Study of the Middle East Veterinary Vaccine Industry (2023 to 2033)

The Middle East veterinary vaccine industry size is projected to expand at a 4% CAGR through 2033. The demand outlook for veterinary vaccines in the Middle East is US$ 627.1 million in 2023. By 2033, sales of veterinary vaccines in the Middle East are anticipated to cross a valuation of US$ 973.8 million.

Attributes Details
Middle East Veterinary Vaccine Industry Size in 2023 US$ 627.1 million
Expected Industry Size by 2033 US$ 973.8 million
Value-based CAGR from 2023 to 2033 4%

Key Trends Influencing Demand through 2033

  • The Middle East is investing significant resources in biotechnology and research, supporting innovation in veterinary vaccine manufacturing. This investment strengthens the industry's capabilities and raises the region's profile in the global biotech industry.
  • Significant zoonotic disease outbreaks, such as MERS, have occurred in the region. Recognizing the significant health and economic ramifications, the Middle East prioritizes animal immunization to protect both animal and human health.
  • The Middle East has a thriving livestock industry that caters to the expanding demand for meat, dairy, and poultry products. Veterinary vaccinations are critical for minimizing illness risks and guaranteeing these animals' health and production.
  • The region quickly embraces digital technologies and data-driven solutions for disease tracking, animal health surveillance, and optimizing vaccine distribution. This digital shift improves efficiency and effectiveness across the veterinary vaccine value chain.
  • The Middle East has a large population of camels, which play a substantial role in the region's culture and commerce. As a result, there is a unique tendency toward creating camel-specific vaccines to serve the camel farming and racing businesses.
  • Advanced data analytics and predictive modeling are being used to forecast illness outbreaks, enabling preventive immunization efforts and reducing the region's economic burden from diseases.
  • To increase animal health and alleviate poverty, certain Middle Eastern governments are working to ensure equitable access to veterinary vaccines for underprivileged and nomadic people, particularly in distant places.

Don't pay for what you don't need

Customize your report by selecting specific countries or regions and save 30%!

Key Insights on Emerging Opportunities in the Middle East Veterinary Vaccine Industry

  • Companies can create hydroponic feed solutions and additives that are designed to improve animal health and vaccination success. This meets the growing demand for new solutions in the agriculture industry.
  • Businesses can tackle logistical problems and ensure a consistent vaccine supply by creating vaccine banks and cold storage facilities. This is especially advantageous for rural and underserved areas, as it reduces supply chain disturbances.
  • As livestock farming becomes more popular in the Middle East, insurance firms should embrace the chance to offer livestock insurance, including coverage against illnesses and vaccination-related losses, expanding their portfolio and meeting the demands of livestock owners.
  • Developing training institutes dedicated to training veterinarians and animal health professionals is a lucrative business. These facilities cater to the workforce's training needs by offering vaccine delivery, disease control, and biosecurity procedure courses.
  • Middle Eastern collaborations with global vaccine makers can result in knowledge transfer and license agreements. This association promotes the exchange of information and technology, which can lead to localized vaccine manufacturing and export prospects

Historical Performance of the Middle East Veterinary Vaccine Industry

Attributes Details
Middle East Veterinary Vaccine Industry Size (2018) US$ 510.8 million
Middle East Veterinary Vaccine Industry Size (2022) US$ 627.1 million

The Middle East's livestock and agriculture industries have grown significantly in recent years due to rising demand for meat, dairy, and other animal-based products. This developing industry requires the use of veterinary vaccinations to ensure the health and productivity of animals, consequently stimulating the veterinary vaccine sector's growth. Biosecurity and disease management have become critical in the livestock and agriculture industries of the Middle East. Robust procedures, including vaccination, are required to prevent disease spread within and across animal populations, fueling industry growth.

Businesses in the Middle East veterinary vaccine industry are vying to minimize the environmental effect of vaccine manufacturing and distribution as sustainability goals gain importance in the Middle East. Green practices and eco-friendly solutions are in line with the region's environmental goals. Animal disease outbreaks can have significant economic and public health consequences in the Middle East. By guaranteeing animal health through vaccination, the region mitigates these dangers while protecting the food supply and public health interests.

In the coming years, the global demand for animal-based protein is predicted to rise further as the world's population grows with rising incomes. This will increase the demand for efficient disease prevention methods such as veterinary vaccinations. Biotechnology, genetics, and immunology advancements result in the development of more accurate, efficacious, and novel veterinary vaccines. These innovations improve the industry's capacity to tackle new and emerging illnesses. Recognizing the interconnection of human, animal, and environmental health, the One Health concept is expected to foster collaboration between the veterinary and human health sectors for disease management initiatives.

Sabyasachi Ghosh
Sabyasachi Ghosh

Principal Consultant

Talk to Analyst

Find your sweet spots for generating winning opportunities in this market.

Comparative View of the Adjacent Middle East Veterinary Vaccine Industry

Two industries related to the Veterinary Vaccine and Veterinary Hospital industries. As per the analysis, the rising pet adoption is anticipated to fuel expansion across the mentioned industries. The rising advancements in animal health monitoring and disease surveillance are expected to boost revenues across these industries. The ongoing developments in vaccine production are expected to influence growth across these industries. The rising awareness for animal welfare will also gain prominence and create opportunities across these industries in the coming years.

Middle East Veterinary Vaccine Industry:

Attributes Middle East Veterinary Vaccine Industry
CAGR (2023 to 2033) 4%
Market Value (2023) US$ 627.1 million
Growth Factors Increasing investment in aquaculture Rising focus on livestock health
Future Opportunities Development of halal-certified veterinary vaccines
Market Trends Advancements in disease forecasting and monitoring solutions

Veterinary Vaccine Industry:

Attributes Veterinary Vaccine Industry
CAGR (2023 to 2033) 6.2%
Market Value (2023) US$ 11.3 billion
Growth Factors Increasing expenditure on pet care Rising adoption of efficient immunizations
Future Opportunities Increased government investments
Market Trends Rising advancements in vaccine development

Veterinary Hospital Industry:

Attributes Veterinary Hospital Industry
CAGR (2023 to 2033) 6.2%
Market Value (2023) US$ 79.54 billion
Growth Factors Continued modernization of advanced veterinary healthcare infrastructure. Increasing pet adoption globally.
Future Opportunities Increased veterinary healthcare expenditure.
Market Trends Growing awareness for animal welfare.

Category-wise Insights

Rising Investments to Boost Local Manufacturing Fuel Demand for Attenuated Live Vaccines

Leading Vaccine Technology in the Middle East Attenuated Live Vaccines Technology
Total Value Share (2023) 34.20%

The Middle East's surging investments in biotechnology and research are boosting the domestic production of attenuated live vaccines. This coincides with the region's objective of vaccine self-sufficiency and enables customization to meet particular area disease issues. Live attenuated vaccines have proven to be useful in preventing a variety of animal illnesses. They provide a cost-effective disease management option, which is especially tempting in the Middle East's livestock and agriculture industries, where economic concerns are essential.

Government-led Initiatives Promote Livestock Sector’s Growth in the Middle East

Leading Animal Type in the Middle East Livestock Animals
Total Value Share (2023) 74.40%

Governments around the Middle East are fiercely encouraging the expansion of the livestock sector, with many of their activities involving disease control through vaccination campaigns. The Middle East is home to a diversified animal population, which includes cattle, sheep, goats, and even camels. Each species has unique disease problems, requiring a range of vaccinations carefully tailored to each animal type's needs. Several Middle Eastern nations are making huge investments in agriculture and animal husbandry to improve food security. As the livestock industry grows, the demand for veterinary vaccinations to protect animal health and production aligns with national food security goals.

Get the data you need at a Fraction of the cost

Personalize your report by choosing insights you need
and save 40%!

Country-wise Insights

Countries Value-based CAGR (2023 to 2033)
KSA 4.9%
UAE 5.1%
Iran 4.3%
Israel 4.0%
Egypt 5.3%

KSA’s Vision 2030 Initiatives Boost Investments in Veterinary Vaccine Industry

Sales of veterinary vaccines in the Kingdom of Saudi Arabia (KSA) are expected to rise at a 4.9% CAGR through 2033. The Kingdom of Saudi Arabia's Vision 2030 strategic efforts focus on non-oil industries such as agriculture and healthcare. This commitment drives investments in the veterinary vaccine business, aligning with the country's economic diversification objectives. Royal support for agriculture, particularly animal husbandry, leads to greater financing and incentives for veterinary vaccine research and manufacturing. This royal encouragement has created a favorable atmosphere for the growth of the veterinary vaccine sector.

Rising Focus on Genetic Improvements Gain Prominence in the UAE

The UAE veterinary vaccines industry is projected to expand at a 5.1% CAGR through 2033. The UAE's emphasis on genetic development in livestock breeds to increase performance has increased the demand for vaccinations that protect genetically superior animals. As a result, customized vaccinations that target these breeds' specific health needs are gaining popularity. The UAE's efforts in state-of-the-art research and development, including genomics and biotechnology, have sparked the development of novel vaccinations suited to the particular animal health issues in the area. These developments are attracting both domestic and international stakeholders.

Iran’s Geostrategic Location Provides a Gateway for Trade

Sales of veterinary vaccines in Iran are expected to rise at a 4.3% CAGR through 2033. Iran has been subjected to international sanctions, driving self-sufficiency measures in a variety of industries, including healthcare. These self-sufficiency programs have supported the veterinary vaccine sector, leading to greater domestic manufacturing and an emphasis on innovation. The strategic location of Iran serves as a gateway for trade for Asia, Europe, and the Middle East. As trade networks increase, there is a greater demand for livestock vaccination to fulfill international animal health standards and enable commerce, hence promoting the expansion of the veterinary vaccine industry.

Geopolitical Tensions Largely Impact Industry Expansion in Israel

The demand for veterinary vaccines in Israel is likely to increase at a 4.0% CAGR through 2033. However, in light of recent geopolitical tensions between Israel and its neighboring countries, revenues of several industries are expected to be affected. Despite this, the Israeli government's significant emphasis on national security extends to biosecurity issues. The veterinary vaccine sector is vital in preserving cattle and animal populations, guaranteeing food security, and preventing bioterrorism.

Increasing Focus on Food Security Drives Investments in Egypt

The veterinary vaccine industry in Egypt is anticipated to accelerate at a 5.3% CAGR through 2033. The Egyptian government's emphasis on food security and self-sufficiency encourages investments in the livestock sector and the veterinary vaccination business. The industry is critical to ensuring the health and well-being of cattle, therefore contributing to the nation's food security goals. Egypt's participation in Pan-African agricultural projects and collaborations has resulted in a rising need for vaccinations that are compliant with regional disease control and trade standards, establishing the country as a prominent participant in African agriculture.

Competitive Landscape in the Middle East Veterinary Vaccine Industry

The Middle East veterinary vaccines industry's competitive environment is defined by a broad array of players and entities, each of which contributes to the sector's growth and development. Multinational pharmaceutical conglomerates like Zoetis, MSD Animal Health (Merck Animal Health in the United States and Canada), and Boehringer Ingelheim have a prominent presence in the region. These firms provide a wide range of vaccines, building on established brand awareness using their global reach and substantial research capabilities. Key players provide complete solutions to a wide range of animal health issues across the Middle East.

Recent Developments in the Middle East Veterinary Vaccine Industry

  • Bill Gates, Co-chair of the Bill & Melinda Gates Foundation, announced new investments at the 2023 Grand Challenges Annual Meeting in October 2023 to advance access to mRNA research and vaccine manufacturing technology. This will support low- and middle-income countries' (LMICs') capacity to develop large-scale, high-quality, lifesaving vaccines. The decision builds on the foundation's more than 20 years of experience working with vaccine producers in LMICs, as well as the chance to use recent scientific discoveries to develop low-cost, high-quality health tools that reach more people throughout the world.
  • Kansas State University's College of Veterinary Medicine announced the establishment of the new Center on Vaccine Evaluation and Alternatives for Antimicrobials, or CVEAA, in July 2023 to promote animal vaccine development and use.

Key Players in the Middle East Veterinary Vaccine Industry

  • JOVAC
  • Bioveta, Inc.
  • Intervac Pvt. Ltd.
  • Zoetis
  • Elanco
  • Merial
  • Merck & Co. Inc.
  • Bayer Pharma AG
  • Ceva
  • Boehringer Ingelheim
  • MSD Animal Health

Middle East Veterinary Vaccine Industry Segmentation

By Vaccine:

  • Attenuated Live Vaccines
  • Inactivated Vaccines
  • Toxoid Vaccines
  • DNA Vaccines
  • Recombinant Vaccines
  • Others

By Animal:

  • Companion Animals
    • Canine
    • Avian
    • Feline
  • Livestock Animals
    • Aquatic
    • Bovine
    • Porcine
    • Small Ruminant
    • Poultry
  • Equine

By Disease Indication:

  • Foot and Mouth Disease
  • Newcastle Disease
  • PPRS
  • Canine Parvovirus
  • Brucellosis
  • Avian Influenza
  • Others

By End User:

  • Hospital Pharmacies
  • Veterinary Clinics
  • Private Veterinary Pharmacies
  • Others

By Country:

  • UAE
  • KSA
  • Turkey
  • Jordan
  • Sudan
  • Egypt
  • Rest of MEA

Frequently Asked Questions

How Big is the Middle East Veterinary Vaccines Industry?

The Middle East veterinary vaccine market size is US$ 627.1 million in 2023.

What is the Projected CAGR of the Middle East Veterinary Vaccines Industry?

The Middle East veterinary vaccine market is expected to rise at a 4% CAGR through 2033.

What is the Middle East Veterinary Vaccine Industry Outlook?

The Middle East veterinary vaccine market size will be worth US$ 973.8 million by 2033.

What is the Preferred Vaccine Technology in the Middle East Veterinary Vaccine Industry?

The demand for attenuated live vaccine technology is high in the industry.

Which Country is Leading the Middle East Veterinary Vaccines Industry Growth?

The Middle East veterinary vaccine market size in Egypt is expected to rise at a 5.3% CAGR through 2033.

Table of Content

1. Executive Summary

    1.1. Market Outlook

    1.2. Demand-side Trends

    1.3. Supply-side Trends

    1.4. Technology Roadmap Analysis

    1.5. Analysis and Recommendations

2. Market Overview

    2.1. Market Coverage / Taxonomy

    2.2. Market Definition / Scope / Limitations

3. Market Background

    3.1. Market Dynamics

        3.1.1. Drivers

        3.1.2. Restraints

        3.1.3. Opportunity

        3.1.4. Trends

    3.2. Scenario Forecast

        3.2.1. Demand in Optimistic Scenario

        3.2.2. Demand in Likely Scenario

        3.2.3. Demand in Conservative Scenario

    3.3. Opportunity Map Analysis

    3.4. Product Life Cycle Analysis

    3.5. Supply Chain Analysis

        3.5.1. Supply Side Participants and their Roles

            3.5.1.1. Producers

            3.5.1.2. Mid-Level Participants (Traders/ Agents/ Brokers)

            3.5.1.3. Wholesalers and Distributors

        3.5.2. Value Added and Value Created at Node in the Supply Chain

        3.5.3. List of Raw Material Suppliers

        3.5.4. List of Existing and Potential Buyer’s

    3.6. Investment Feasibility Matrix

    3.7. Value Chain Analysis

        3.7.1. Profit Margin Analysis

        3.7.2. Wholesalers and Distributors

        3.7.3. Retailers

    3.8. PESTLE and Porter’s Analysis

    3.9. Regulatory Landscape

        3.9.1. By Key Regions

        3.9.2. By Key Countries

    3.10. Regional Parent Market Outlook

    3.11. Production and Consumption Statistics

    3.12. Import and Export Statistics

4. Market Analysis 2018 to 2022 and Forecast, 2023 to 2033

    4.1. Historical Market Size Value (US$ Million) & Volume (Units) Analysis, 2018 to 2022

    4.2. Current and Future Market Size Value (US$ Million) & Volume (Units) Projections, 2023 to 2033

        4.2.1. Y-o-Y Growth Trend Analysis

        4.2.2. Absolute $ Opportunity Analysis

5. Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Vaccine

    5.1. Introduction / Key Findings

    5.2. Historical Market Size Value (US$ Million) & Volume (Units) Analysis By Vaccine, 2018 to 2022

    5.3. Current and Future Market Size Value (US$ Million) & Volume (Units) Analysis and Forecast By Vaccine, 2023 to 2033

        5.3.1. Attenuated Live Vaccines

        5.3.2. Inactivated Vaccines

        5.3.3. Toxoid Vaccines

        5.3.4. DNA Vaccines

        5.3.5. Recombinant Vaccines

        5.3.6. Others

    5.4. Y-o-Y Growth Trend Analysis By Vaccine, 2018 to 2022

    5.5. Absolute $ Opportunity Analysis By Vaccine, 2023 to 2033

6. Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Animal

    6.1. Introduction / Key Findings

    6.2. Historical Market Size Value (US$ Million) & Volume (Units) Analysis By Animal, 2018 to 2022

    6.3. Current and Future Market Size Value (US$ Million) & Volume (Units) Analysis and Forecast By Animal, 2023 to 2033

        6.3.1. Companion Animals

            6.3.1.1. Canine

            6.3.1.2. Avian

            6.3.1.3. Feline

        6.3.2. Livestock Animals

            6.3.2.1. Aquatic

            6.3.2.2. Bovine

            6.3.2.3. Porcine

            6.3.2.4. Small Ruminant

            6.3.2.5. Poultry

        6.3.3. Equine

    6.4. Y-o-Y Growth Trend Analysis By Animal, 2018 to 2022

    6.5. Absolute $ Opportunity Analysis By Animal, 2023 to 2033

7. Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Disease Indication

    7.1. Introduction / Key Findings

    7.2. Historical Market Size Value (US$ Million) & Volume (Units) Analysis By Disease Indication, 2018 to 2022

    7.3. Current and Future Market Size Value (US$ Million) & Volume (Units) Analysis and Forecast By Disease Indication, 2023 to 2033

        7.3.1. Foot and Mouth Disease

        7.3.2. Newcastle Disease

        7.3.3. PPRS

        7.3.4. Canine Parvovirus

        7.3.5. Brucellosis

        7.3.6. Avian Influenza

        7.3.7. Others

    7.4. Y-o-Y Growth Trend Analysis By Disease Indication, 2018 to 2022

    7.5. Absolute $ Opportunity Analysis By Disease Indication, 2023 to 2033

8. Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By End-User

    8.1. Introduction / Key Findings

    8.2. Historical Market Size Value (US$ Million) & Volume (Units) Analysis By End-User, 2018 to 2022

    8.3. Current and Future Market Size Value (US$ Million) & Volume (Units) Analysis and Forecast By End-User, 2023 to 2033

        8.3.1. Hospital Pharmacies

        8.3.2. Veterinary Clinics

        8.3.3. Private Veterinary Pharmacies

        8.3.4. Others

    8.4. Y-o-Y Growth Trend Analysis By End-User, 2018 to 2022

    8.5. Absolute $ Opportunity Analysis By End-User, 2023 to 2033

9. Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country

    9.1. Introduction

    9.2. Historical Market Size Value (US$ Million) & Volume (Units) Analysis By Region, 2018 to 2022

    9.3. Current Market Size Value (US$ Million) & Volume (Units) Analysis and Forecast By Region, 2023 to 2033

        9.3.1. UAE

        9.3.2. KSA

        9.3.3. Turkey

        9.3.4. Jordan

        9.3.5. Sudan

        9.3.6. Egypt

        9.3.7. Rest of Middle East

    9.4. Market Attractiveness Analysis By Region

10. UAE Market Analysis 2018 to 2022 and Forecast 2023 to 2033

    10.1. Historical Market Size Value (US$ Million) & Volume (Units) Trend Analysis By Market Taxonomy, 2018 to 2022

    10.2. Market Size Value (US$ Million) & Volume (Units) Forecast By Market Taxonomy, 2023 to 2033

        10.2.1. By Country

        10.2.2. By Vaccine

        10.2.3. By Animal

        10.2.4. By Disease Indication

        10.2.5. By End-User

    10.3. Market Attractiveness Analysis

        10.3.1. By Country

        10.3.2. By Vaccine

        10.3.3. By Animal

        10.3.4. By Disease Indication

        10.3.5. By End-User

    10.4. Key Takeaways

11. KSA Market Analysis 2018 to 2022 and Forecast 2023 to 2033

    11.1. Historical Market Size Value (US$ Million) & Volume (Units) Trend Analysis By Market Taxonomy, 2018 to 2022

    11.2. Market Size Value (US$ Million) & Volume (Units) Forecast By Market Taxonomy, 2023 to 2033

        11.2.1. By Country

        11.2.2. By Vaccine

        11.2.3. By Animal

        11.2.4. By Disease Indication

        11.2.5. By End-User

    11.3. Market Attractiveness Analysis

        11.3.1. By Country

        11.3.2. By Vaccine

        11.3.3. By Animal

        11.3.4. By Disease Indication

        11.3.5. By End-User

    11.4. Key Takeaways

12. Turkey Market Analysis 2018 to 2022 and Forecast 2023 to 2033

    12.1. Historical Market Size Value (US$ Million) & Volume (Units) Trend Analysis By Market Taxonomy, 2018 to 2022

    12.2. Market Size Value (US$ Million) & Volume (Units) Forecast By Market Taxonomy, 2023 to 2033

        12.2.1. By Country

        12.2.2. By Vaccine

        12.2.3. By Animal

        12.2.4. By Disease Indication

        12.2.5. By End-User

    12.3. Market Attractiveness Analysis

        12.3.1. By Country

        12.3.2. By Vaccine

        12.3.3. By Animal

        12.3.4. By Disease Indication

        12.3.5. By End-User

    12.4. Key Takeaways

13. Jordan Market Analysis 2018 to 2022 and Forecast 2023 to 2033

    13.1. Historical Market Size Value (US$ Million) & Volume (Units) Trend Analysis By Market Taxonomy, 2018 to 2022

    13.2. Market Size Value (US$ Million) & Volume (Units) Forecast By Market Taxonomy, 2023 to 2033

        13.2.1. By Country

        13.2.2. By Vaccine

        13.2.3. By Animal

        13.2.4. By Disease Indication

        13.2.5. By End-User

    13.3. Market Attractiveness Analysis

        13.3.1. By Country

        13.3.2. By Vaccine

        13.3.3. By Animal

        13.3.4. By Disease Indication

        13.3.5. By End-User

    13.4. Key Takeaways

14. Sudan Market Analysis 2018 to 2022 and Forecast 2023 to 2033

    14.1. Historical Market Size Value (US$ Million) & Volume (Units) Trend Analysis By Market Taxonomy, 2018 to 2022

    14.2. Market Size Value (US$ Million) & Volume (Units) Forecast By Market Taxonomy, 2023 to 2033

        14.2.1. By Country

        14.2.2. By Vaccine

        14.2.3. By Animal

        14.2.4. By Disease Indication

        14.2.5. By End-User

    14.3. Market Attractiveness Analysis

        14.3.1. By Country

        14.3.2. By Vaccine

        14.3.3. By Animal

        14.3.4. By Disease Indication

        14.3.5. By End-User

    14.4. Key Takeaways

15. Egypt Market Analysis 2018 to 2022 and Forecast 2023 to 2033

    15.1. Historical Market Size Value (US$ Million) & Volume (Units) Trend Analysis By Market Taxonomy, 2018 to 2022

    15.2. Market Size Value (US$ Million) & Volume (Units) Forecast By Market Taxonomy, 2023 to 2033

        15.2.1. By Country

        15.2.2. By Vaccine

        15.2.3. By Animal

        15.2.4. By Disease Indication

        15.2.5. By End-User

    15.3. Market Attractiveness Analysis

        15.3.1. By Country

        15.3.2. By Vaccine

        15.3.3. By Animal

        15.3.4. By Disease Indication

        15.3.5. By End-User

    15.4. Key Takeaways

16. Rest of Market Analysis 2018 to 2022 and Forecast 2023 to 2033

    16.1. Historical Market Size Value (US$ Million) & Volume (Units) Trend Analysis By Market Taxonomy, 2018 to 2022

    16.2. Market Size Value (US$ Million) & Volume (Units) Forecast By Market Taxonomy, 2023 to 2033

        16.2.1. By Country

        16.2.2. By Vaccine

        16.2.3. By Animal

        16.2.4. By Disease Indication

        16.2.5. By End-User

    16.3. Market Attractiveness Analysis

        16.3.1. By Country

        16.3.2. By Vaccine

        16.3.3. By Animal

        16.3.4. By Disease Indication

        16.3.5. By End-User

    16.4. Key Takeaways

17. Market Structure Analysis

    17.1. Competition Dashboard

    17.2. Competition Benchmarking

    17.3. Market Share Analysis of Top Players

        17.3.1. By Regional

        17.3.2. By Vaccine

        17.3.3. By Animal

        17.3.4. By Disease Indication

        17.3.5. By End-User

18. Competition Analysis

    18.1. Competition Deep Dive

        18.1.1. JOVAC

            18.1.1.1. Overview

            18.1.1.2. Product Portfolio

            18.1.1.3. Profitability by Market Segments

            18.1.1.4. Sales Footprint

            18.1.1.5. Strategy Overview

                18.1.1.5.1. Marketing Strategy

                18.1.1.5.2. Product Strategy

                18.1.1.5.3. Channel Strategy

        18.1.2. Bioveta, Inc.

            18.1.2.1. Overview

            18.1.2.2. Product Portfolio

            18.1.2.3. Profitability by Market Segments

            18.1.2.4. Sales Footprint

            18.1.2.5. Strategy Overview

                18.1.2.5.1. Marketing Strategy

                18.1.2.5.2. Product Strategy

                18.1.2.5.3. Channel Strategy

        18.1.3. Intervac Pvt. Ltd.

            18.1.3.1. Overview

            18.1.3.2. Product Portfolio

            18.1.3.3. Profitability by Market Segments

            18.1.3.4. Sales Footprint

            18.1.3.5. Strategy Overview

                18.1.3.5.1. Marketing Strategy

                18.1.3.5.2. Product Strategy

                18.1.3.5.3. Channel Strategy

        18.1.4. Zoetis

            18.1.4.1. Overview

            18.1.4.2. Product Portfolio

            18.1.4.3. Profitability by Market Segments

            18.1.4.4. Sales Footprint

            18.1.4.5. Strategy Overview

                18.1.4.5.1. Marketing Strategy

                18.1.4.5.2. Product Strategy

                18.1.4.5.3. Channel Strategy

        18.1.5. Elanco

            18.1.5.1. Overview

            18.1.5.2. Product Portfolio

            18.1.5.3. Profitability by Market Segments

            18.1.5.4. Sales Footprint

            18.1.5.5. Strategy Overview

                18.1.5.5.1. Marketing Strategy

                18.1.5.5.2. Product Strategy

                18.1.5.5.3. Channel Strategy

        18.1.6. Merial

            18.1.6.1. Overview

            18.1.6.2. Product Portfolio

            18.1.6.3. Profitability by Market Segments

            18.1.6.4. Sales Footprint

            18.1.6.5. Strategy Overview

                18.1.6.5.1. Marketing Strategy

                18.1.6.5.2. Product Strategy

                18.1.6.5.3. Channel Strategy

        18.1.7. Merck & Co. Inc.

            18.1.7.1. Overview

            18.1.7.2. Product Portfolio

            18.1.7.3. Profitability by Market Segments

            18.1.7.4. Sales Footprint

            18.1.7.5. Strategy Overview

                18.1.7.5.1. Marketing Strategy

                18.1.7.5.2. Product Strategy

                18.1.7.5.3. Channel Strategy

        18.1.8. Bayer Pharma AG

            18.1.8.1. Overview

            18.1.8.2. Product Portfolio

            18.1.8.3. Profitability by Market Segments

            18.1.8.4. Sales Footprint

            18.1.8.5. Strategy Overview

                18.1.8.5.1. Marketing Strategy

                18.1.8.5.2. Product Strategy

                18.1.8.5.3. Channel Strategy

        18.1.9. Ceva

            18.1.9.1. Overview

            18.1.9.2. Product Portfolio

            18.1.9.3. Profitability by Market Segments

            18.1.9.4. Sales Footprint

            18.1.9.5. Strategy Overview

                18.1.9.5.1. Marketing Strategy

                18.1.9.5.2. Product Strategy

                18.1.9.5.3. Channel Strategy

        18.1.10. Boehringer Ingelheim

            18.1.10.1. Overview

            18.1.10.2. Product Portfolio

            18.1.10.3. Profitability by Market Segments

            18.1.10.4. Sales Footprint

            18.1.10.5. Strategy Overview

                18.1.10.5.1. Marketing Strategy

                18.1.10.5.2. Product Strategy

                18.1.10.5.3. Channel Strategy

19. Assumptions & Acronyms Used

20. Research Methodology

Don't pay for what you don't need

Customize your report by selecting specific countries or regions and save 30%!

List of Tables

Table 1: Market Value (US$ Million) Forecast by Region, 2018 to 2033

Table 2: Market Volume (Units) Forecast by Region, 2018 to 2033

Table 3: Market Value (US$ Million) Forecast by Vaccine, 2018 to 2033

Table 4: Market Volume (Units) Forecast by Vaccine, 2018 to 2033

Table 5: Market Value (US$ Million) Forecast by Animal, 2018 to 2033

Table 6: Market Volume (Units) Forecast by Animal, 2018 to 2033

Table 7: Market Value (US$ Million) Forecast by Disease Indication, 2018 to 2033

Table 8: Market Volume (Units) Forecast by Disease Indication, 2018 to 2033

Table 9: Market Value (US$ Million) Forecast by End-User, 2018 to 2033

Table 10: Market Volume (Units) Forecast by End-User, 2018 to 2033

Table 11: UAE Market Value (US$ Million) Forecast by Country, 2018 to 2033

Table 12: UAE Market Volume (Units) Forecast by Country, 2018 to 2033

Table 13: UAE Market Value (US$ Million) Forecast by Vaccine, 2018 to 2033

Table 14: UAE Market Volume (Units) Forecast by Vaccine, 2018 to 2033

Table 15: UAE Market Value (US$ Million) Forecast by Animal, 2018 to 2033

Table 16: UAE Market Volume (Units) Forecast by Animal, 2018 to 2033

Table 17: UAE Market Value (US$ Million) Forecast by Disease Indication, 2018 to 2033

Table 18: UAE Market Volume (Units) Forecast by Disease Indication, 2018 to 2033

Table 19: UAE Market Value (US$ Million) Forecast by End-User, 2018 to 2033

Table 20: UAE Market Volume (Units) Forecast by End-User, 2018 to 2033

Table 21: KSA Market Value (US$ Million) Forecast by Country, 2018 to 2033

Table 22: KSA Market Volume (Units) Forecast by Country, 2018 to 2033

Table 23: KSA Market Value (US$ Million) Forecast by Vaccine, 2018 to 2033

Table 24: KSA Market Volume (Units) Forecast by Vaccine, 2018 to 2033

Table 25: KSA Market Value (US$ Million) Forecast by Animal, 2018 to 2033

Table 26: KSA Market Volume (Units) Forecast by Animal, 2018 to 2033

Table 27: KSA Market Value (US$ Million) Forecast by Disease Indication, 2018 to 2033

Table 28: KSA Market Volume (Units) Forecast by Disease Indication, 2018 to 2033

Table 29: KSA Market Value (US$ Million) Forecast by End-User, 2018 to 2033

Table 30: KSA Market Volume (Units) Forecast by End-User, 2018 to 2033

Table 31: Turkey Market Value (US$ Million) Forecast by Country, 2018 to 2033

Table 32: Turkey Market Volume (Units) Forecast by Country, 2018 to 2033

Table 33: Turkey Market Value (US$ Million) Forecast by Vaccine, 2018 to 2033

Table 34: Turkey Market Volume (Units) Forecast by Vaccine, 2018 to 2033

Table 35: Turkey Market Value (US$ Million) Forecast by Animal, 2018 to 2033

Table 36: Turkey Market Volume (Units) Forecast by Animal, 2018 to 2033

Table 37: Turkey Market Value (US$ Million) Forecast by Disease Indication, 2018 to 2033

Table 38: Turkey Market Volume (Units) Forecast by Disease Indication, 2018 to 2033

Table 39: Turkey Market Value (US$ Million) Forecast by End-User, 2018 to 2033

Table 40: Turkey Market Volume (Units) Forecast by End-User, 2018 to 2033

Table 41: Jordan Market Value (US$ Million) Forecast by Country, 2018 to 2033

Table 42: Jordan Market Volume (Units) Forecast by Country, 2018 to 2033

Table 43: Jordan Market Value (US$ Million) Forecast by Vaccine, 2018 to 2033

Table 44: Jordan Market Volume (Units) Forecast by Vaccine, 2018 to 2033

Table 45: Jordan Market Value (US$ Million) Forecast by Animal, 2018 to 2033

Table 46: Jordan Market Volume (Units) Forecast by Animal, 2018 to 2033

Table 47: Jordan Market Value (US$ Million) Forecast by Disease Indication, 2018 to 2033

Table 48: Jordan Market Volume (Units) Forecast by Disease Indication, 2018 to 2033

Table 49: Jordan Market Value (US$ Million) Forecast by End-User, 2018 to 2033

Table 50: Jordan Market Volume (Units) Forecast by End-User, 2018 to 2033

Table 51: Sudan Market Value (US$ Million) Forecast by Country, 2018 to 2033

Table 52: Sudan Market Volume (Units) Forecast by Country, 2018 to 2033

Table 53: Sudan Market Value (US$ Million) Forecast by Vaccine, 2018 to 2033

Table 54: Sudan Market Volume (Units) Forecast by Vaccine, 2018 to 2033

Table 55: Sudan Market Value (US$ Million) Forecast by Animal, 2018 to 2033

Table 56: Sudan Market Volume (Units) Forecast by Animal, 2018 to 2033

Table 57: Sudan Market Value (US$ Million) Forecast by Disease Indication, 2018 to 2033

Table 58: Sudan Market Volume (Units) Forecast by Disease Indication, 2018 to 2033

Table 59: Sudan Market Value (US$ Million) Forecast by End-User, 2018 to 2033

Table 60: Sudan Market Volume (Units) Forecast by End-User, 2018 to 2033

Table 61: Egypt Market Value (US$ Million) Forecast by Country, 2018 to 2033

Table 62: Egypt Market Volume (Units) Forecast by Country, 2018 to 2033

Table 63: Egypt Market Value (US$ Million) Forecast by Vaccine, 2018 to 2033

Table 64: Egypt Market Volume (Units) Forecast by Vaccine, 2018 to 2033

Table 65: Egypt Market Value (US$ Million) Forecast by Animal, 2018 to 2033

Table 66: Egypt Market Volume (Units) Forecast by Animal, 2018 to 2033

Table 67: Egypt Market Value (US$ Million) Forecast by Disease Indication, 2018 to 2033

Table 68: Egypt Market Volume (Units) Forecast by Disease Indication, 2018 to 2033

Table 69: Egypt Market Value (US$ Million) Forecast by End-User, 2018 to 2033

Table 70: Egypt Market Volume (Units) Forecast by End-User, 2018 to 2033

Table 71: Rest of Market Value (US$ Million) Forecast by Country, 2018 to 2033

Table 72: Rest of Market Volume (Units) Forecast by Country, 2018 to 2033

Table 73: Rest of Market Value (US$ Million) Forecast by Vaccine, 2018 to 2033

Table 74: Rest of Market Volume (Units) Forecast by Vaccine, 2018 to 2033

Table 75: Rest of Market Value (US$ Million) Forecast by Animal, 2018 to 2033

Table 76: Rest of Market Volume (Units) Forecast by Animal, 2018 to 2033

Table 77: Rest of Market Value (US$ Million) Forecast by Disease Indication, 2018 to 2033

Table 78: Rest of Market Volume (Units) Forecast by Disease Indication, 2018 to 2033

Table 79: Rest of Market Value (US$ Million) Forecast by End-User, 2018 to 2033

Table 80: Rest of Market Volume (Units) Forecast by End-User, 2018 to 2033
Sabyasachi Ghosh
Sabyasachi Ghosh

Principal Consultant

Talk to Analyst

Find your sweet spots for generating winning opportunities in this market.

List of Charts

Figure 1: Market Value (US$ Million) by Vaccine, 2023 to 2033

Figure 2: Market Value (US$ Million) by Animal, 2023 to 2033

Figure 3: Market Value (US$ Million) by Disease Indication, 2023 to 2033

Figure 4: Market Value (US$ Million) by End-User, 2023 to 2033

Figure 5: Market Value (US$ Million) by Region, 2023 to 2033

Figure 6: Market Value (US$ Million) Analysis by Region, 2018 to 2033

Figure 7: Market Volume (Units) Analysis by Region, 2018 to 2033

Figure 8: Market Value Share (%) and BPS Analysis by Region, 2023 to 2033

Figure 9: Market Y-o-Y Growth (%) Projections by Region, 2023 to 2033

Figure 10: Market Value (US$ Million) Analysis by Vaccine, 2018 to 2033

Figure 11: Market Volume (Units) Analysis by Vaccine, 2018 to 2033

Figure 12: Market Value Share (%) and BPS Analysis by Vaccine, 2023 to 2033

Figure 13: Market Y-o-Y Growth (%) Projections by Vaccine, 2023 to 2033

Figure 14: Market Value (US$ Million) Analysis by Animal, 2018 to 2033

Figure 15: Market Volume (Units) Analysis by Animal, 2018 to 2033

Figure 16: Market Value Share (%) and BPS Analysis by Animal, 2023 to 2033

Figure 17: Market Y-o-Y Growth (%) Projections by Animal, 2023 to 2033

Figure 18: Market Value (US$ Million) Analysis by Disease Indication, 2018 to 2033

Figure 19: Market Volume (Units) Analysis by Disease Indication, 2018 to 2033

Figure 20: Market Value Share (%) and BPS Analysis by Disease Indication, 2023 to 2033

Figure 21: Market Y-o-Y Growth (%) Projections by Disease Indication, 2023 to 2033

Figure 22: Market Value (US$ Million) Analysis by End-User, 2018 to 2033

Figure 23: Market Volume (Units) Analysis by End-User, 2018 to 2033

Figure 24: Market Value Share (%) and BPS Analysis by End-User, 2023 to 2033

Figure 25: Market Y-o-Y Growth (%) Projections by End-User, 2023 to 2033

Figure 26: Market Attractiveness by Vaccine, 2023 to 2033

Figure 27: Market Attractiveness by Animal, 2023 to 2033

Figure 28: Market Attractiveness by Disease Indication, 2023 to 2033

Figure 29: Market Attractiveness by End-User, 2023 to 2033

Figure 30: Market Attractiveness by Region, 2023 to 2033

Figure 31: UAE Market Value (US$ Million) by Vaccine, 2023 to 2033

Figure 32: UAE Market Value (US$ Million) by Animal, 2023 to 2033

Figure 33: UAE Market Value (US$ Million) by Disease Indication, 2023 to 2033

Figure 34: UAE Market Value (US$ Million) by End-User, 2023 to 2033

Figure 35: UAE Market Value (US$ Million) by Country, 2023 to 2033

Figure 36: UAE Market Value (US$ Million) Analysis by Country, 2018 to 2033

Figure 37: UAE Market Volume (Units) Analysis by Country, 2018 to 2033

Figure 38: UAE Market Value Share (%) and BPS Analysis by Country, 2023 to 2033

Figure 39: UAE Market Y-o-Y Growth (%) Projections by Country, 2023 to 2033

Figure 40: UAE Market Value (US$ Million) Analysis by Vaccine, 2018 to 2033

Figure 41: UAE Market Volume (Units) Analysis by Vaccine, 2018 to 2033

Figure 42: UAE Market Value Share (%) and BPS Analysis by Vaccine, 2023 to 2033

Figure 43: UAE Market Y-o-Y Growth (%) Projections by Vaccine, 2023 to 2033

Figure 44: UAE Market Value (US$ Million) Analysis by Animal, 2018 to 2033

Figure 45: UAE Market Volume (Units) Analysis by Animal, 2018 to 2033

Figure 46: UAE Market Value Share (%) and BPS Analysis by Animal, 2023 to 2033

Figure 47: UAE Market Y-o-Y Growth (%) Projections by Animal, 2023 to 2033

Figure 48: UAE Market Value (US$ Million) Analysis by Disease Indication, 2018 to 2033

Figure 49: UAE Market Volume (Units) Analysis by Disease Indication, 2018 to 2033

Figure 50: UAE Market Value Share (%) and BPS Analysis by Disease Indication, 2023 to 2033

Figure 51: UAE Market Y-o-Y Growth (%) Projections by Disease Indication, 2023 to 2033

Figure 52: UAE Market Value (US$ Million) Analysis by End-User, 2018 to 2033

Figure 53: UAE Market Volume (Units) Analysis by End-User, 2018 to 2033

Figure 54: UAE Market Value Share (%) and BPS Analysis by End-User, 2023 to 2033

Figure 55: UAE Market Y-o-Y Growth (%) Projections by End-User, 2023 to 2033

Figure 56: UAE Market Attractiveness by Vaccine, 2023 to 2033

Figure 57: UAE Market Attractiveness by Animal, 2023 to 2033

Figure 58: UAE Market Attractiveness by Disease Indication, 2023 to 2033

Figure 59: UAE Market Attractiveness by End-User, 2023 to 2033

Figure 60: UAE Market Attractiveness by Country, 2023 to 2033

Figure 61: KSA Market Value (US$ Million) by Vaccine, 2023 to 2033

Figure 62: KSA Market Value (US$ Million) by Animal, 2023 to 2033

Figure 63: KSA Market Value (US$ Million) by Disease Indication, 2023 to 2033

Figure 64: KSA Market Value (US$ Million) by End-User, 2023 to 2033

Figure 65: KSA Market Value (US$ Million) by Country, 2023 to 2033

Figure 66: KSA Market Value (US$ Million) Analysis by Country, 2018 to 2033

Figure 67: KSA Market Volume (Units) Analysis by Country, 2018 to 2033

Figure 68: KSA Market Value Share (%) and BPS Analysis by Country, 2023 to 2033

Figure 69: KSA Market Y-o-Y Growth (%) Projections by Country, 2023 to 2033

Figure 70: KSA Market Value (US$ Million) Analysis by Vaccine, 2018 to 2033

Figure 71: KSA Market Volume (Units) Analysis by Vaccine, 2018 to 2033

Figure 72: KSA Market Value Share (%) and BPS Analysis by Vaccine, 2023 to 2033

Figure 73: KSA Market Y-o-Y Growth (%) Projections by Vaccine, 2023 to 2033

Figure 74: KSA Market Value (US$ Million) Analysis by Animal, 2018 to 2033

Figure 75: KSA Market Volume (Units) Analysis by Animal, 2018 to 2033

Figure 76: KSA Market Value Share (%) and BPS Analysis by Animal, 2023 to 2033

Figure 77: KSA Market Y-o-Y Growth (%) Projections by Animal, 2023 to 2033

Figure 78: KSA Market Value (US$ Million) Analysis by Disease Indication, 2018 to 2033

Figure 79: KSA Market Volume (Units) Analysis by Disease Indication, 2018 to 2033

Figure 80: KSA Market Value Share (%) and BPS Analysis by Disease Indication, 2023 to 2033

Figure 81: KSA Market Y-o-Y Growth (%) Projections by Disease Indication, 2023 to 2033

Figure 82: KSA Market Value (US$ Million) Analysis by End-User, 2018 to 2033

Figure 83: KSA Market Volume (Units) Analysis by End-User, 2018 to 2033

Figure 84: KSA Market Value Share (%) and BPS Analysis by End-User, 2023 to 2033

Figure 85: KSA Market Y-o-Y Growth (%) Projections by End-User, 2023 to 2033

Figure 86: KSA Market Attractiveness by Vaccine, 2023 to 2033

Figure 87: KSA Market Attractiveness by Animal, 2023 to 2033

Figure 88: KSA Market Attractiveness by Disease Indication, 2023 to 2033

Figure 89: KSA Market Attractiveness by End-User, 2023 to 2033

Figure 90: KSA Market Attractiveness by Country, 2023 to 2033

Figure 91: Turkey Market Value (US$ Million) by Vaccine, 2023 to 2033

Figure 92: Turkey Market Value (US$ Million) by Animal, 2023 to 2033

Figure 93: Turkey Market Value (US$ Million) by Disease Indication, 2023 to 2033

Figure 94: Turkey Market Value (US$ Million) by End-User, 2023 to 2033

Figure 95: Turkey Market Value (US$ Million) by Country, 2023 to 2033

Figure 96: Turkey Market Value (US$ Million) Analysis by Country, 2018 to 2033

Figure 97: Turkey Market Volume (Units) Analysis by Country, 2018 to 2033

Figure 98: Turkey Market Value Share (%) and BPS Analysis by Country, 2023 to 2033

Figure 99: Turkey Market Y-o-Y Growth (%) Projections by Country, 2023 to 2033

Figure 100: Turkey Market Value (US$ Million) Analysis by Vaccine, 2018 to 2033

Figure 101: Turkey Market Volume (Units) Analysis by Vaccine, 2018 to 2033

Figure 102: Turkey Market Value Share (%) and BPS Analysis by Vaccine, 2023 to 2033

Figure 103: Turkey Market Y-o-Y Growth (%) Projections by Vaccine, 2023 to 2033

Figure 104: Turkey Market Value (US$ Million) Analysis by Animal, 2018 to 2033

Figure 105: Turkey Market Volume (Units) Analysis by Animal, 2018 to 2033

Figure 106: Turkey Market Value Share (%) and BPS Analysis by Animal, 2023 to 2033

Figure 107: Turkey Market Y-o-Y Growth (%) Projections by Animal, 2023 to 2033

Figure 108: Turkey Market Value (US$ Million) Analysis by Disease Indication, 2018 to 2033

Figure 109: Turkey Market Volume (Units) Analysis by Disease Indication, 2018 to 2033

Figure 110: Turkey Market Value Share (%) and BPS Analysis by Disease Indication, 2023 to 2033

Figure 111: Turkey Market Y-o-Y Growth (%) Projections by Disease Indication, 2023 to 2033

Figure 112: Turkey Market Value (US$ Million) Analysis by End-User, 2018 to 2033

Figure 113: Turkey Market Volume (Units) Analysis by End-User, 2018 to 2033

Figure 114: Turkey Market Value Share (%) and BPS Analysis by End-User, 2023 to 2033

Figure 115: Turkey Market Y-o-Y Growth (%) Projections by End-User, 2023 to 2033

Figure 116: Turkey Market Attractiveness by Vaccine, 2023 to 2033

Figure 117: Turkey Market Attractiveness by Animal, 2023 to 2033

Figure 118: Turkey Market Attractiveness by Disease Indication, 2023 to 2033

Figure 119: Turkey Market Attractiveness by End-User, 2023 to 2033

Figure 120: Turkey Market Attractiveness by Country, 2023 to 2033

Figure 121: Jordan Market Value (US$ Million) by Vaccine, 2023 to 2033

Figure 122: Jordan Market Value (US$ Million) by Animal, 2023 to 2033

Figure 123: Jordan Market Value (US$ Million) by Disease Indication, 2023 to 2033

Figure 124: Jordan Market Value (US$ Million) by End-User, 2023 to 2033

Figure 125: Jordan Market Value (US$ Million) by Country, 2023 to 2033

Figure 126: Jordan Market Value (US$ Million) Analysis by Country, 2018 to 2033

Figure 127: Jordan Market Volume (Units) Analysis by Country, 2018 to 2033

Figure 128: Jordan Market Value Share (%) and BPS Analysis by Country, 2023 to 2033

Figure 129: Jordan Market Y-o-Y Growth (%) Projections by Country, 2023 to 2033

Figure 130: Jordan Market Value (US$ Million) Analysis by Vaccine, 2018 to 2033

Figure 131: Jordan Market Volume (Units) Analysis by Vaccine, 2018 to 2033

Figure 132: Jordan Market Value Share (%) and BPS Analysis by Vaccine, 2023 to 2033

Figure 133: Jordan Market Y-o-Y Growth (%) Projections by Vaccine, 2023 to 2033

Figure 134: Jordan Market Value (US$ Million) Analysis by Animal, 2018 to 2033

Figure 135: Jordan Market Volume (Units) Analysis by Animal, 2018 to 2033

Figure 136: Jordan Market Value Share (%) and BPS Analysis by Animal, 2023 to 2033

Figure 137: Jordan Market Y-o-Y Growth (%) Projections by Animal, 2023 to 2033

Figure 138: Jordan Market Value (US$ Million) Analysis by Disease Indication, 2018 to 2033

Figure 139: Jordan Market Volume (Units) Analysis by Disease Indication, 2018 to 2033

Figure 140: Jordan Market Value Share (%) and BPS Analysis by Disease Indication, 2023 to 2033

Figure 141: Jordan Market Y-o-Y Growth (%) Projections by Disease Indication, 2023 to 2033

Figure 142: Jordan Market Value (US$ Million) Analysis by End-User, 2018 to 2033

Figure 143: Jordan Market Volume (Units) Analysis by End-User, 2018 to 2033

Figure 144: Jordan Market Value Share (%) and BPS Analysis by End-User, 2023 to 2033

Figure 145: Jordan Market Y-o-Y Growth (%) Projections by End-User, 2023 to 2033

Figure 146: Jordan Market Attractiveness by Vaccine, 2023 to 2033

Figure 147: Jordan Market Attractiveness by Animal, 2023 to 2033

Figure 148: Jordan Market Attractiveness by Disease Indication, 2023 to 2033

Figure 149: Jordan Market Attractiveness by End-User, 2023 to 2033

Figure 150: Jordan Market Attractiveness by Country, 2023 to 2033

Figure 151: Sudan Market Value (US$ Million) by Vaccine, 2023 to 2033

Figure 152: Sudan Market Value (US$ Million) by Animal, 2023 to 2033

Figure 153: Sudan Market Value (US$ Million) by Disease Indication, 2023 to 2033

Figure 154: Sudan Market Value (US$ Million) by End-User, 2023 to 2033

Figure 155: Sudan Market Value (US$ Million) by Country, 2023 to 2033

Figure 156: Sudan Market Value (US$ Million) Analysis by Country, 2018 to 2033

Figure 157: Sudan Market Volume (Units) Analysis by Country, 2018 to 2033

Figure 158: Sudan Market Value Share (%) and BPS Analysis by Country, 2023 to 2033

Figure 159: Sudan Market Y-o-Y Growth (%) Projections by Country, 2023 to 2033

Figure 160: Sudan Market Value (US$ Million) Analysis by Vaccine, 2018 to 2033

Figure 161: Sudan Market Volume (Units) Analysis by Vaccine, 2018 to 2033

Figure 162: Sudan Market Value Share (%) and BPS Analysis by Vaccine, 2023 to 2033

Figure 163: Sudan Market Y-o-Y Growth (%) Projections by Vaccine, 2023 to 2033

Figure 164: Sudan Market Value (US$ Million) Analysis by Animal, 2018 to 2033

Figure 165: Sudan Market Volume (Units) Analysis by Animal, 2018 to 2033

Figure 166: Sudan Market Value Share (%) and BPS Analysis by Animal, 2023 to 2033

Figure 167: Sudan Market Y-o-Y Growth (%) Projections by Animal, 2023 to 2033

Figure 168: Sudan Market Value (US$ Million) Analysis by Disease Indication, 2018 to 2033

Figure 169: Sudan Market Volume (Units) Analysis by Disease Indication, 2018 to 2033

Figure 170: Sudan Market Value Share (%) and BPS Analysis by Disease Indication, 2023 to 2033

Figure 171: Sudan Market Y-o-Y Growth (%) Projections by Disease Indication, 2023 to 2033

Figure 172: Sudan Market Value (US$ Million) Analysis by End-User, 2018 to 2033

Figure 173: Sudan Market Volume (Units) Analysis by End-User, 2018 to 2033

Figure 174: Sudan Market Value Share (%) and BPS Analysis by End-User, 2023 to 2033

Figure 175: Sudan Market Y-o-Y Growth (%) Projections by End-User, 2023 to 2033

Figure 176: Sudan Market Attractiveness by Vaccine, 2023 to 2033

Figure 177: Sudan Market Attractiveness by Animal, 2023 to 2033

Figure 178: Sudan Market Attractiveness by Disease Indication, 2023 to 2033

Figure 179: Sudan Market Attractiveness by End-User, 2023 to 2033

Figure 180: Sudan Market Attractiveness by Country, 2023 to 2033

Figure 181: Egypt Market Value (US$ Million) by Vaccine, 2023 to 2033

Figure 182: Egypt Market Value (US$ Million) by Animal, 2023 to 2033

Figure 183: Egypt Market Value (US$ Million) by Disease Indication, 2023 to 2033

Figure 184: Egypt Market Value (US$ Million) by End-User, 2023 to 2033

Figure 185: Egypt Market Value (US$ Million) by Country, 2023 to 2033

Figure 186: Egypt Market Value (US$ Million) Analysis by Country, 2018 to 2033

Figure 187: Egypt Market Volume (Units) Analysis by Country, 2018 to 2033

Figure 188: Egypt Market Value Share (%) and BPS Analysis by Country, 2023 to 2033

Figure 189: Egypt Market Y-o-Y Growth (%) Projections by Country, 2023 to 2033

Figure 190: Egypt Market Value (US$ Million) Analysis by Vaccine, 2018 to 2033

Figure 191: Egypt Market Volume (Units) Analysis by Vaccine, 2018 to 2033

Figure 192: Egypt Market Value Share (%) and BPS Analysis by Vaccine, 2023 to 2033

Figure 193: Egypt Market Y-o-Y Growth (%) Projections by Vaccine, 2023 to 2033

Figure 194: Egypt Market Value (US$ Million) Analysis by Animal, 2018 to 2033

Figure 195: Egypt Market Volume (Units) Analysis by Animal, 2018 to 2033

Figure 196: Egypt Market Value Share (%) and BPS Analysis by Animal, 2023 to 2033

Figure 197: Egypt Market Y-o-Y Growth (%) Projections by Animal, 2023 to 2033

Figure 198: Egypt Market Value (US$ Million) Analysis by Disease Indication, 2018 to 2033

Figure 199: Egypt Market Volume (Units) Analysis by Disease Indication, 2018 to 2033

Figure 200: Egypt Market Value Share (%) and BPS Analysis by Disease Indication, 2023 to 2033

Figure 201: Egypt Market Y-o-Y Growth (%) Projections by Disease Indication, 2023 to 2033

Figure 202: Egypt Market Value (US$ Million) Analysis by End-User, 2018 to 2033

Figure 203: Egypt Market Volume (Units) Analysis by End-User, 2018 to 2033

Figure 204: Egypt Market Value Share (%) and BPS Analysis by End-User, 2023 to 2033

Figure 205: Egypt Market Y-o-Y Growth (%) Projections by End-User, 2023 to 2033

Figure 206: Egypt Market Attractiveness by Vaccine, 2023 to 2033

Figure 207: Egypt Market Attractiveness by Animal, 2023 to 2033

Figure 208: Egypt Market Attractiveness by Disease Indication, 2023 to 2033

Figure 209: Egypt Market Attractiveness by End-User, 2023 to 2033

Figure 210: Egypt Market Attractiveness by Country, 2023 to 2033

Figure 211: Rest of Market Value (US$ Million) by Vaccine, 2023 to 2033

Figure 212: Rest of Market Value (US$ Million) by Animal, 2023 to 2033

Figure 213: Rest of Market Value (US$ Million) by Disease Indication, 2023 to 2033

Figure 214: Rest of Market Value (US$ Million) by End-User, 2023 to 2033

Figure 215: Rest of Market Value (US$ Million) by Country, 2023 to 2033

Figure 216: Rest of Market Value (US$ Million) Analysis by Country, 2018 to 2033

Figure 217: Rest of Market Volume (Units) Analysis by Country, 2018 to 2033

Figure 218: Rest of Market Value Share (%) and BPS Analysis by Country, 2023 to 2033

Figure 219: Rest of Market Y-o-Y Growth (%) Projections by Country, 2023 to 2033

Figure 220: Rest of Market Value (US$ Million) Analysis by Vaccine, 2018 to 2033

Figure 221: Rest of Market Volume (Units) Analysis by Vaccine, 2018 to 2033

Figure 222: Rest of Market Value Share (%) and BPS Analysis by Vaccine, 2023 to 2033

Figure 223: Rest of Market Y-o-Y Growth (%) Projections by Vaccine, 2023 to 2033

Figure 224: Rest of Market Value (US$ Million) Analysis by Animal, 2018 to 2033

Figure 225: Rest of Market Volume (Units) Analysis by Animal, 2018 to 2033

Figure 226: Rest of Market Value Share (%) and BPS Analysis by Animal, 2023 to 2033

Figure 227: Rest of Market Y-o-Y Growth (%) Projections by Animal, 2023 to 2033

Figure 228: Rest of Market Value (US$ Million) Analysis by Disease Indication, 2018 to 2033

Figure 229: Rest of Market Volume (Units) Analysis by Disease Indication, 2018 to 2033

Figure 230: Rest of Market Value Share (%) and BPS Analysis by Disease Indication, 2023 to 2033

Figure 231: Rest of Market Y-o-Y Growth (%) Projections by Disease Indication, 2023 to 2033

Figure 232: Rest of Market Value (US$ Million) Analysis by End-User, 2018 to 2033

Figure 233: Rest of Market Volume (Units) Analysis by End-User, 2018 to 2033

Figure 234: Rest of Market Value Share (%) and BPS Analysis by End-User, 2023 to 2033

Figure 235: Rest of Market Y-o-Y Growth (%) Projections by End-User, 2023 to 2033

Figure 236: Rest of Market Attractiveness by Vaccine, 2023 to 2033

Figure 237: Rest of Market Attractiveness by Animal, 2023 to 2033

Figure 238: Rest of Market Attractiveness by Disease Indication, 2023 to 2033

Figure 239: Rest of Market Attractiveness by End-User, 2023 to 2033

Figure 240: Rest of Market Attractiveness by Country, 2023 to 2033

Recommendations

Healthcare

Veterinary Pain Management Drugs Market

Published : January 2023

Healthcare

Veterinary Vaccines Market

Published : January 2023

Explore Healthcare Insights

View Reports

Veterinary Vaccine Industry Analysis in Middle East